These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. New directions in the prevention and treatment of schizophrenia: a biological perspective. Wyatt RJ; Apud JA; Potkin S Psychiatry; 1996; 59(4):357-70. PubMed ID: 9029657 [TBL] [Abstract][Full Text] [Related]
5. Beyond the facts in schizophrenia: closing the gaps in diagnosis, pathophysiology, and treatment. Nasrallah H; Tandon R; Keshavan M Epidemiol Psychiatr Sci; 2011 Dec; 20(4):317-27. PubMed ID: 22201209 [TBL] [Abstract][Full Text] [Related]
6. [Early intervention in increased risk for schizophrenic illnesses. Multimodal psychotherapy--antipsychotic drugs only in treatment failure]. Wieneke A; Bechdolf A; Schultze-Lutter F MMW Fortschr Med; 2000 Mar; 142(10):30-2. PubMed ID: 10748600 [TBL] [Abstract][Full Text] [Related]
9. The staging model in schizophrenia, and its clinical implications. Agius M; Goh C; Ulhaq S; McGorry P Psychiatr Danub; 2010 Jun; 22(2):211-20. PubMed ID: 20562749 [TBL] [Abstract][Full Text] [Related]
10. Adjunctive psychosocial therapies for the treatment of schizophrenia. Patterson TL; Leeuwenkamp OR Schizophr Res; 2008 Mar; 100(1-3):108-19. PubMed ID: 18226500 [TBL] [Abstract][Full Text] [Related]
11. Gerard E. Hogarty (1935--2006): combining science and humanism to improve the care of persons with schizophrenia. Eack SM; Schooler NR; Ganguli R Schizophr Bull; 2007 Sep; 33(5):1056-62. PubMed ID: 17617662 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or cul-de-sac? Buckley PF; Stahl SM Acta Psychiatr Scand; 2007 Feb; 115(2):93-100. PubMed ID: 17244172 [TBL] [Abstract][Full Text] [Related]
13. Clinical management of negative symptoms of schizophrenia: An update. Tsapakis EM; Dimopoulou T; Tarazi FI Pharmacol Ther; 2015 Sep; 153():135-47. PubMed ID: 26116809 [TBL] [Abstract][Full Text] [Related]
14. World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia. Tandon R; Belmaker RH; Gattaz WF; Lopez-Ibor JJ; Okasha A; Singh B; Stein DJ; Olie JP; Fleischhacker WW; Moeller HJ; Schizophr Res; 2008 Mar; 100(1-3):20-38. PubMed ID: 18243663 [TBL] [Abstract][Full Text] [Related]
15. Antipsychotic treatment of schizophrenia: an update. Bruijnzeel D; Suryadevara U; Tandon R Asian J Psychiatr; 2014 Oct; 11():3-7. PubMed ID: 25216917 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents. Miyamoto S; Miyake N; Jarskog LF; Fleischhacker WW; Lieberman JA Mol Psychiatry; 2012 Dec; 17(12):1206-27. PubMed ID: 22584864 [TBL] [Abstract][Full Text] [Related]
17. Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Tandon R; Nasrallah HA; Keshavan MS Schizophr Res; 2009 May; 110(1-3):1-23. PubMed ID: 19328655 [TBL] [Abstract][Full Text] [Related]
18. Developing treatments for impaired cognition in schizophrenia. Minzenberg MJ; Carter CS Trends Cogn Sci; 2012 Jan; 16(1):35-42. PubMed ID: 22178120 [TBL] [Abstract][Full Text] [Related]
19. The potential of immune biomarkers to advance personalized medicine approaches for schizophrenia. Cox D; Chan MK; Bahn S J Nerv Ment Dis; 2015 May; 203(5):393-9. PubMed ID: 25919386 [TBL] [Abstract][Full Text] [Related]
20. My father, my life, and chlorpromazine. Artigues MF N C Med J; 2000; 61(2):90-4. PubMed ID: 10737030 [No Abstract] [Full Text] [Related] [Next] [New Search]